Valiant Laboratories Limited Share Price & Stock Analysis

Valiant Laboratories Limited (NSE: VALIANTLAB, BSE: 543998) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹594 Cr, it ranks #1,907 by market cap among the 6,197 Indian listed companies on FinBizNet, and #27 of 63 in Pharmaceuticals. At ₹104.96 (as of 16 Nov 2026), the share price is 25.8% below its 52-week high of ₹141.38 and 112.0% above its 52-week low of ₹49.51. The share price is up 24.9% over one year and up 33.7% over three months.

Key Metrics

Current Price₹104.96
Market Cap₹594 Cr
NSE SymbolVALIANTLAB
BSE Code543998
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E RatioNot meaningful (loss)
Return on Equity-1.20%
Return on Assets0.14%
52-Week Range₹49.51 – ₹141.38
1-Year Price Change+24.9%
3-Month Price Change+33.7%
Beta (1Y)0.61
HeadquartersMumbai, Maharashtra
Websitevaliantlabs.in

Latest Quarterly Results — Q2 FY27

Revenue₹117 Cr
Net Profit₹0 Cr
Net Margin0.4%
EPS (Basic)₹0.08
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Valiant Laboratories Limited Quarterly Revenue and Profit Trend

Valiant Laboratories Limited reported revenue of ₹117 Cr in Q2 FY27, up 152.7% from ₹46 Cr in Q2 FY26 and up 1.3% from ₹115 Cr in Q1 FY27. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹0 Cr in Q2 FY26 (up 105.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹46 Cr (Q2 FY26) to ₹117 Cr (Q2 FY27). The company reported a net loss in 1 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹117 Cr₹0 Cr0.4%
Q1 FY27₹115 Cr₹21 Cr18.3%
Q4 FY26₹92 Cr₹2 Cr1.9%
Q3 FY26₹52 Cr−₹7 Cr−13.5%
Q2 FY26₹46 Cr₹0 Cr0.4%
Q1 FY26₹47 Cr₹2 Cr3.9%
Q4 FY25₹58 Cr₹1 Cr1.2%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 74.94% of Valiant Laboratories Limited's shares as of Sept 2026, unchanged from Sept 2025.

About Valiant Laboratories Limited

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Products and Services

1. Manufacturing of Chemicals Business-This segment manufactures paracetamol in various grades. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Manufacturing of Chemicals Business-100%

Valiant Laboratories Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Valiant Laboratories Limited₹594 Crn/m-1.20%₹117 Cr+24.9%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Valiant Laboratories Limited?

Valiant Laboratories Limited is trading at ₹104.96, with a market capitalisation of ₹594 Cr.

Which sector does Valiant Laboratories Limited belong to?

Valiant Laboratories Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Valiant Laboratories Limited?

Valiant Laboratories Limited has a return on equity of -1.20%.

What is the stock symbol of Valiant Laboratories Limited?

Valiant Laboratories Limited is listed on the NSE under the symbol VALIANTLAB and on the BSE under the scrip code 543998.

How has Valiant Laboratories Limited's share price moved over the past year?

Valiant Laboratories Limited's share price is up 24.9% over one year and up 33.7% over three months. Its 52-week range is ₹49.51 to ₹141.38.

What were Valiant Laboratories Limited's latest quarterly results?

In Q2 FY27, Valiant Laboratories Limited reported revenue of ₹117 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.08 (consolidated, parsed from the company's exchange filing).

How have Valiant Laboratories Limited's revenue and profit changed over the past year?

Valiant Laboratories Limited reported revenue of ₹117 Cr in Q2 FY27, up 152.7% from ₹46 Cr in Q2 FY26 and up 1.3% from ₹115 Cr in Q1 FY27.

What is the promoter holding in Valiant Laboratories Limited?

Promoters held 74.94% of Valiant Laboratories Limited's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.